[Congressional Record Volume 168, Number 198 (Tuesday, December 20, 2022)]
[Senate]
[Pages S9665-S9666]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 6584. Mr. HEINRICH (for Mr. Reed) proposed an amendment to the 
bill S. 4120, to maximize discovery, and accelerate development and 
availability of promising childhood cancer treatments, and for other 
purposes; as follows:

        Strike all after the enacting clause and insert the 
     following:

     SECTION 1. SHORT TITLE.

       This Act may be cited as the ``Childhood Cancer 
     Survivorship, Treatment, Access, and Research Reauthorization 
     Act of 2022'' or the ``Childhood Cancer STAR Reauthorization 
     Act''.

     SEC. 2. REAUTHORIZING AND IMPROVING THE CHILDHOOD STAR ACT.

       (a) Children's Cancer Biorepositories.--Section 417E of the 
     Public Health Service Act (42 U.S.C. 285a-11) is amended--
       (1) in subsection (a)--
       (A) in paragraph (2)(A), by inserting before the period at 
     the end of the second sentence the following: ``, such as 
     collected samples of both solid tumor cancer and paired 
     samples'';
       (B) in paragraph (9), by striking ``Childhood Cancer 
     Survivorship, Treatment, Access, and Research Act of 2018'' 
     and inserting ``Childhood Cancer Survivorship, Treatment, 
     Access, and Research Reauthorization Act of 2022'';
       (C) by redesignating paragraph (10) as paragraph (11); and
       (D) by inserting after paragraph (9) the following:
       ``(10) Report on researcher access to children's cancer 
     biorepository samples.--Not later than 2 years after the date 
     of enactment of the Childhood Cancer Survivorship, Treatment, 
     Access, and Research Reauthorization Act of 2022, the 
     Director of NIH shall--
       ``(A) conduct a review of the procedures established under 
     paragraph (2)(C) and other policies or procedures related to 
     researcher access to such biospecimens to identify any 
     opportunities to reduce administrative burden, consistent 
     with paragraph (2)(D), in a manner that protects personal 
     privacy to the extent required by applicable Federal and 
     State privacy law, at a minimum; and
       ``(B) submit to the Committee on Health, Education, Labor, 
     and Pensions of the Senate and the Committee on Energy and 
     Commerce of the House of Representatives a report on the 
     findings of the review under subparagraph (A) and whether the 
     Director of NIH plans to make any changes to the policies or 
     procedures considered in such review, based on such 
     findings.''; and
       (2) in subsection (d), by striking ``2019 through 2023'' 
     and inserting ``2024 through 2028''.
       (b) Cancer Survivorship Programs.--Section 201 of the 
     Childhood Cancer Survivorship, Treatment, Access, and 
     Research Act of 2018 (Public Law 115-180) is amended--
       (1) in subsection (a)--
       (A) in the subsection heading, by striking ``Pilot Programs 
     to Explore'' and inserting ``Research to Evaluate''
       (B) in paragraph (1)--
       (i) by striking ``may make awards to eligible entities to 
     establish pilot programs'' and inserting ``shall, as 
     appropriate, make awards to eligible entities to conduct or 
     support research'';
       (ii) by striking ``model systems'' and inserting 
     ``approaches'';
       (iii) by inserting ``and adolescent'' after ``childhood''; 
     and
       (iv) by striking ``evaluation of models for'';
       (C) in paragraph (2)--
       (i) in subparagraph (A), in the matter preceding clause 
     (i), by inserting ``within the existing peer review 
     process,'' after ``practicable,''; and
       (ii) in subparagraph (B)(v), by striking ``in treating 
     survivors of childhood cancers'' and inserting ``in carrying 
     out the activities described in paragraph (1)''; and
       (D) in paragraph (3)(B)(v), by striking ``design of systems 
     for the effective transfer of treatment information and care 
     summaries from cancer care providers to other health care 
     providers'' and inserting ``design tools

[[Page S9666]]

     to support the secure electronic transfer of treatment 
     information and care summaries between health care providers 
     or, as applicable and appropriate, longitudinal childhood 
     cancer survivorship cohorts''; and
       (2) in subsection (b)--
       (A) in each of paragraphs (1) and (2), by striking ``date 
     of enactment of this Act'' and inserting ``date of enactment 
     of the Childhood Cancer Survivorship, Treatment, Access, and 
     Research Reauthorization Act of 2022''; and
       (B) in paragraph (1)--
       (i) by striking subparagraphs (A) and (C);
       (ii) by redesignating subparagraph (B) as subparagraph (A); 
     and
       (iii) by adding at the end the following:
       ``(B) recommendations for enhancing or promoting activities 
     of the Department of Health and Human Services related to 
     workforce development for health care providers who provide 
     psychosocial care to pediatric cancer patients and 
     survivors.''.
                                 ______